Radiological Detection System Development
The Combating Weapons of Mass Destruction (CWMD) Product Improvement line supports obsolescence management and product improvement efforts for overall chemical, radiological, and biological detection and protection for the warfighter for multiple programs of record. Radiological Detection System (RDS) will replace the current radiation detection, indication, and computation (RADIAC) systems used by the Joint Services and will consolidate the capabilities into one joint solution. RDS consists of a handheld base unit with beta/gamma detection capability and six probes. RDS incorporates geolocation data- Global Positioning System interface capability, Network Ready data and lessons learned from Operation TOMODACHI which includes common measurements, common equipment, and adequate sensitivity. RDS benefits the warfighter by providing a common Joint capability to detect, identify, and compute total exposure to multiple radiation types, and reduces the acquisition as well as sustainment costs across the Joint Services by taking advantage of economies of scale. FY 2027 dollars in the amount of $0.488 million supports required radio interoperability testing supporting the net-ready KPP and Follow On Test and Evaluation (FOT&E).
FY2027 planned work Complete Follow-On Test and Evaluation (FOT&E) activities in support of the Net-Ready KPP as well as interoperability testing on the DAGR GPS replacement. Continue Program management and administration processes to include but not limited to program oversight, resource justification, budgeting and programming, milestone and schedule tracking.
FY2026 to FY2027 change Funding increase supports scope of requirements testing and funds needed for completing Follow-On Test and Evaluation (FOT&E) activities.
FY2026 plans — current year Continue addressing radio interoperability to support the Net Ready KPP and continue activities to support follow-on operational test and evaluation (FOT&E).
FY2025 accomplishments Addressed radio interoperability.